Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China

British Journal of Nutrition

Volumn 104, Issue 1, 2010, Pages 118-124

  Guo, Kaiping ^a   Zhang, Bo ^a   Chen, Chaogang ^a   Uchiyama, Shigeto ^b   Ueno, Tomomi ^b   Chen, Yuming ^a   Su, Yixiang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Otsuka Pharmaceutical Company Limited   (Japan)

Author keywords

Blood lipids; Equol; Isoflavones; O desmethylangolensin; Uric acid

Indexed keywords

DAIDZEIN; EQUOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LIPID; URIC ACID; ISOFLAVONE DERIVATIVE; O DESMETHYLANGOLENSIN; O-DESMETHYLANGOLENSIN; PHYTOESTROGEN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; METABOLITE; NORMAL HUMAN; PHENOTYPE; URIC ACID BLOOD LEVEL; URINE LEVEL; WAIST HIP RATIO; BLOOD; CARDIOVASCULAR DISEASE; MEDICAL RECORD; METABOLISM; MIDDLE AGED; RISK FACTOR; URINE;

ADULT; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIET RECORDS; FEMALE; HUMANS; ISOFLAVONES; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; PHYTOESTROGENS; RISK FACTORS; TRIGLYCERIDES; URIC ACID; WAIST-HIP RATIO; YOUNG ADULT;

EID: 77954685031     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510000279     Document Type: Article

References (27)

1. Setchell KD (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68, 1333S-1346S.
2. Hwang CS, Kwak HS, Lim HJ, et al. (2006) Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101, 246-253.
3. Lichtenstein AH (1998) Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128, 1589-1592.
4. Nagata C (2000) Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol 29, 832-836.
5. Setchell KD, Clerici C, Lephart ED, et al. (2005) S-equol, a potent ligand for estrogen receptor beta, is the exclusive enan-tiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr 81, 1072-1109.
6. Schmitt E, Dekant W & Stopper H (2001) Assaying the estro-genicity of phytoestrogens in cells of different estrogen sensitive tissues. Toxicol In Vitro 15, 433-439.
7. Lampe JW, Skor HE, Li S, et al. (2001) Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women. J Nutr 131, 740-744.
8. Rowland IR, Wiseman H, Sanders TA, et al. (2000) Inter-individual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer 36, 27-32.
9. Duncan AM, Merz-Demlow BE, Xu X, et al. (2000) Pre-menopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 9, 581-586.
10. Atkinson C, Newton KM, Bowles EJ, et al. (2008) Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premeno-pausal women in the United States. Am J Clin Nutr 87, 679-687.
11. Song KB, Atkinson C, Frankenfeld CL,et al. (2006) Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J Nutr 136, 1347-1351.
12. Watanabe S, Yamaguchi M, Sobue T, et al. (1998) Pharmacoki-netics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128, 1710-1715.
13. Arai Y, Uehara M, Sato Y, et al. (2000) Comparison of isofla-vones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol 10, 127-135.
14. Setchell KD, Brown NM & Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584.
15. Frankenfeld CL, McTiernan A, Aiello EJ, et al. (2004) Mammo-graphic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women. Cancer Epidemiol Biomarkers Prev 13, 1156-1162.
16. Frankenfeld CL, McTiernan A, Thomas WK, et al. (2006) Post-menopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas 53, 315-324.
17. Lundh TJ, Pettersson H & Kiessling KH (1988) Liquid chroma-tographic determination of the estrogens daidzein, formonone-tin, coumestrol, and equol in bovine blood plasma and urine. J Assoc Off Anal Chem 71, 938-941.
18. Setchell KDR & Cole SJ (2006) Method of defining equol-producer status and its frequency among vegetarians. J Nutr 136, 2188-2193.
19. Moore WE & Moore LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61, 3202-3207.
20. Cassidy A, Brown JE, Hawdon A, et al. (2006) Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136, 45-51.
21. Hopkins MJ & Macfarlane GT (2002) Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 51, 448-454.
22. Hopkins MJ, Sharp R & Macfarlane GT (2001) Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 48, 198-205.
23. Sacks FM, Lichtenstein A, Van Horn L, et al. (2006) Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113, 1034-1044. (Pubitemid 43879479)
24. Kreijkamp-Kaspers S, Kok L, Bots ML, et al. (2005) Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr 81, 189-195. (Pubitemid 43073393)
25. Fang J & Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 283, 2404-2410.
26. Zhang B, Chen YM, Huang LL, et al. (2008) Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis 198, 403-411.
27. Howes JB, Sullivan D, Lai N, et al. (2000) The effects of dietary supplementation with isoflavones from red clover on the lipopro-tein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152, 143-147.